PTN+胶质母细胞瘤亚克隆通过免疫重编程驱动远处复发
本研究对胶质母细胞瘤患者的原发与远处复发配对标本行单细胞RNA测序,并行生物信息学、Co-IP、体外共培养及原位异种移植验证。发现远处复发灶中抗炎单核细胞来源TAM扩增、CD8+T细胞与Tregs共富集;PTN+肿瘤细胞通过PTN-NCL旁分泌促进该TAM极化,阻断此轴可抑制增殖、迁移、侵袭及TAM极化,沉默PTN可减少TAM浸润、降低颅内肿瘤负荷并延长生存。
要点
- 远处复发GBM以免疫微环境重构为特征,而非单纯遗传漂变
- PTN+肿瘤细胞经PTN-NCL旁分泌驱动抗炎TAM极化
- 靶向PTN或NCL可减弱胶质瘤恶性表型及TAM极化
核心结论
- 远处复发GBM由重构的免疫生态位定义,而非仅由遗传漂变驱动。
- PTN+肿瘤细胞与抗炎单核细胞来源TAM的旁分泌互作是促瘤微环境的关键引擎,可作为治疗靶点。
研究设计与样本
- 对GBM患者的原发与远处复发配对肿瘤标本行单细胞RNA测序,并设独立局部复发对照队列。
- 整合Milo差异丰度检验、CellChat细胞通讯推断和CNV分析,结合临床Co-IP验证、双向体外共培养及原位异种移植小鼠模型。
主要发现
- 远处复发灶微环境重塑,表现为抗炎单核细胞来源TAM扩增及CD8+T细胞与Tregs paradoxical共富集。
- OPC样PTN+肿瘤细胞经PTN与NCL互作促进抗炎TAM极化;Co-IP证实人远处复发组织中两蛋白直接物理结合。
- 靶向肿瘤细胞PTN或巨噬细胞NCL解耦该通讯,显著减弱胶质瘤细胞增殖、迁移、侵袭及巨噬细胞极化。
- 体内沉默PTN显著减少抗炎TAM浸润、抑制颅内肿瘤负荷并延长荷瘤小鼠总生存。
临床怎么用
- 远处复发GBM的评估可关注免疫生态位重构,而不仅限于肿瘤细胞遗传特征。
- PTN-NCL旁分泌轴可作为干预远处复发促瘤微环境的候选靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Distant recurrence (DR) represents a distinct and lethal trajectory in glioblastoma (GBM), characterized by the colonization of spatially isolated neural niches. The mechanisms by which disseminated tumor cells remodel the microenvironment to overcome anatomical and immunological barriers remain poorly understood. This study aimed to decode the immune ecosystem of DR and elucidate the intercellular crosstalk driving this lethal dissemination. METHODS: We performed single-cell RNA sequencing (scRNA-seq) on paired primary and DR tumor specimens from GBM patients, alongside an independent local recurrence (LR) control cohort, to map dynamic cellular shifts. Bioinformatic analyses, including differential abundance testing (Milo), cell-cell communication inference (CellChat), and copy number variation (CNV) analysis, were integrated with clinical co-immunoprecipitation (Co-IP) validation, bidirectional in vitro co-culture assays, and an orthotopic xenograft mouse model. RESULTS: Our high-resolution atlas revealed a profound remodeling of the microenvironment in DR lesions, characterized by a specific expansion of anti-inflammatory monocyte-derived tumor-associated macrophages (Anti_infl-TAM) and a paradoxical co-enrichment of CD8 + T cells and Tregs. Mechanistically, an OPC-like subpopulation of PTN+ tumor cells acted as a "paracrine architect," promoting Anti_infl-TAM polarization through the interaction between PTN and NCL. Co-IP assays confirmed direct physical binding of these two proteins in human DR tissues. Functional and bidirectional knockdown assays demonstrated that decoupling this cellular communication, achieved by targeting either PTN in tumor cells or NCL in macrophages, significantly attenuated glioma cell proliferation, migration, invasion, and macrophage polarization. In vivo, silencing PTN markedly reduced Anti_infl-TAM infiltration, suppressed intracranial tumor burden, and prolonged overall survival in tumor-bearing mice. CONCLUSION: This study establishes that DR GBM is defined by a reconfigured immune niche rather than mere genetic drift. The paracrine crosstalk between PTN+ tumor cells and Anti_infl-TAM serves as a critical engine of this permissive soil, offering a promising therapeutic target to disrupt the supportive microenvironment in distant recurrent GBM.
引用
- Yan X, Hu J, Hu Y, et al. A PTN+ glioblastoma subclone orchestrates immune reprogramming to drive distant recurrence. J Neurooncol. 2026. PMID: 42931974. doi:10.1007/s11060-026-05840-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。